Infectious Diseases
  • Article
  • Aug 20 2021

A new study will build upon three decades of research aimed at understanding Borrelia burgdorferi, the bacteria that causes Lyme disease.

  • Article
  • May 4 2021

Researchers from UK College of Nursing are surveying frontline workers in order to improve infection control practices in health care settings as part of Project Firstline.

  • Article
  • Nov 5 2020

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

  • Article
  • Oct 26 2020

Kelly G. Pennell, Gill Associate Professor in the Department of Civil Engineering and director of the UK Superfund Research Center (UK-SRC), has co-authored an article detailing lessons learned about stakeholder engagement and risk communication relevant for COVID-19 and school reopening.

  • Article
  • Sep 17 2020

A new UK study may provide answers for why so many COVID-19 patients experience blood clotting – and why the risk of thrombosis could remain even after the infection clears.

  • Article
  • Jul 22 2020

Dutch is leading the College of Medicine’s COVID-19 Unified Research Experts (CURE) Alliance team, which brings together faculty expertise from multiple disciplines across the university to focus on advising COVID-19 patient care and clinical trials based on emerging research.

  • Article
  • Jul 8 2020

CCTS is partnering with NCATS, the National Center for Data to Health, and around 60 other clinical institutions affiliated with the NCATS Clinical and Translational Science Awards Program to leverage big data in the fight against COVID-19.

  • Article
  • Jun 22 2020

UK announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies.

  • Video
  • Jun 18 2020

UK College of Medicine researchers are using the special antibodies made by alpacas, called nanobodies, to help understand the novel coronavirus and potentially develop a treatment that could protect people from being infected. 

  • Article
  • Jun 17 2020

Known as Serologic Testing to Accelerate Recovery and Transition (START), the study focuses on antibody testing to begin understanding how many people in the region may have already contracted and recovered from COVID-19.